Literature DB >> 2973559

Brain energy metabolism and dopaminergic function in Huntington's disease measured in vivo using positron emission tomography.

K L Leenders1, R S Frackowiak, N Quinn, C D Marsden.   

Abstract

A 48-year-old man with typical Huntington's disease was investigated with computed tomography (CT) and positron emission tomography. Regional cerebral blood flow, oxygen extraction, oxygen and glucose utilisation, L-Dopa uptake, and dopamine (D2) receptor binding were measured using several positron-labelled tracers. CT showed slight atrophy of the head of caudate but no cortical atrophy, although distinct frontal lobe dysfunction was present on psychometric testing. Oxygen and glucose metabolism and cerebral blood flow were decreased in the striata and to a lesser extent in frontal cortex. Cerebral blood flow was in the low normal range throughout the remainder of the brain. A normal metabolic ratio was found in all regions, since the changes in glucose utilisation paralleled those in oxygen consumption. The capacity of the striatum to store dopamine as assessed by L-[18F]-fluorodopa uptake was normal, but dopamine (D2) receptor binding was decreased when compared to normal subjects.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2973559     DOI: 10.1002/mds.870010110

Source DB:  PubMed          Journal:  Mov Disord        ISSN: 0885-3185            Impact factor:   10.338


  34 in total

1.  MRI estimation of global brain oxygen consumption rate.

Authors:  Varsha Jain; Michael C Langham; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2010-04-21       Impact factor: 6.200

Review 2.  PET and movement disorders.

Authors:  D J Brooks; R S Frackowiak
Journal:  J Neurol Neurosurg Psychiatry       Date:  1989-06       Impact factor: 10.154

Review 3.  Positron emission tomography imaging of transplant function.

Authors:  David J Brooks
Journal:  NeuroRx       Date:  2004-10

4.  Non-ketotic hyperglycaemic chorea: a SPECT study.

Authors:  M H Chang; J Y Li; S R Lee; C Y Men
Journal:  J Neurol Neurosurg Psychiatry       Date:  1996-04       Impact factor: 10.154

5.  Positron emission tomography studies of neurotransmitter systems.

Authors:  G V Sawle; D J Brooks
Journal:  J Neurol       Date:  1990-12       Impact factor: 4.849

6.  Method for rapid MRI quantification of global cerebral metabolic rate of oxygen.

Authors:  Suliman Barhoum; Michael C Langham; Jeremy F Magland; Zachary B Rodgers; Cheng Li; Chamith S Rajapakse; Felix W Wehrli
Journal:  J Cereb Blood Flow Metab       Date:  2015-05-13       Impact factor: 6.200

Review 7.  Functional imaging in Huntington's disease.

Authors:  Jane S Paulsen
Journal:  Exp Neurol       Date:  2009-01-03       Impact factor: 5.330

Review 8.  Time-resolved MRI oximetry for quantifying CMRO(2) and vascular reactivity.

Authors:  Felix W Wehrli; Zachary B Rodgers; Varsha Jain; Michael C Langham; Cheng Li; Daniel J Licht; Jeremy Magland
Journal:  Acad Radiol       Date:  2014-02       Impact factor: 3.173

9.  BDNF and Huntingtin protein modifications by manganese: implications for striatal medium spiny neuron pathology in manganese neurotoxicity.

Authors:  Kirstie H Stansfield; Terry Jo Bichell; Aaron B Bowman; Tomás R Guilarte
Journal:  J Neurochem       Date:  2014-09-02       Impact factor: 5.372

10.  Dopamine D1 receptor number--a sensitive PET marker for early brain degeneration in Huntington's disease.

Authors:  G Sedvall; P Karlsson; A Lundin; M Anvret; T Suhara; C Halldin; L Farde
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.